1. Apostolakis, S., Baritaki, S., Kochiadakis, G. E., Igoumenidis, N. E., Panutsopulos, D. and Spandidos, D. A. (2006) Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Thromb Res, : -.
[PMID:16480760]
2. Brand, S., Hofbauer, K., Dambacher, J., Schnitzler, F., Staudinger, T., Pfennig, S., Seiderer, J., Tillack, C., Konrad, A., Göke, B., Ochsenkühn, T. and Lohse, P. (2006) Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Am J Gastroenterol, 101: 99-106.
[PMID:16405540]
3. Brumme, Z. L., Dong, W. W., Chan, K. J., Hogg, R. S., Montaner, J. S., O'Shaughnessy, M. V. and Harrigan, P. R. (2003) Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.
AIDS, 17: 201-208.
[PMID:12545080]
4. Chan, C. C., Tuo, J., Bojanowski, C. M., Csaky, K. G. and Green, W. R. (2005) Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration.
Histol Histopathol, 20: 857-863.
[PMID:15944936]
5. Combadiere, C., Ahuja, S. K. and Murphy, P. M. (1995) Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene.
DNA Cell Biol, 14: 673-680.
[PMID:7646814]
6. Combadiere, C., Gao, J., Tiffany, H. L. and Murphy, P. M. (1998) Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
Biochem Biophys Res Commun, 253: 728-732.
[PMID:9918795]
7. Combadiere, C., Potteaux, S., Gao, J. L., Esposito, B., Casanova, S., Lee, E. J., Debré, P., Tedgui, A., Murphy, P. M. and Mallat, Z. (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
Circulation, 107: 1009-1016.
[PMID:12600915]
8. Combadiere, C., Salzwedel, K., Smith, E. D., Tiffany, H. L., Berger, E. A. and Murphy, P. M. (1998) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.
J. Biol. Chem., 273: 23799-23804.
[PMID:9726990]
9. Damås, J. K., Boullier, A., Waehre, T., Smith, C., Sandberg, W. J., Green, S., Aukrust, P. and Quehenberger, O. (2005) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Arterioscler Thromb Vasc Biol, 25: 2567-2572.
[PMID:16224053]
10. Daoudi, M., Lavergne, E., Garin, A., Tarantino, N., Debré, P., Pincet, F., Combadiere, C. and Deterre, P. (2004) Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1.
J Biol Chem, 279: 19649-19657.
[PMID:14990582]
11. Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., Delfraissy, J. F., McDermott, D. H., Murphy, P. M., Debré, P., Théodorou, I. and Combadiere, C. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.
Science, 287: 2274-2277.
[PMID:10731151]
12. Garin, A., Tarantino, N., Faure, S., Daoudi, M., Lécureuil, C., Bourdais, A., Debré, P., Deterre, P. and Combadiere, C. (2003) Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors.
J Immunol, 171: 5305-5312.
[PMID:14607932]
13. Ghilardi, G., Biondi, M. L., Turri, O., Guagnellini, E. and Scorza, R. (2004) Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
Stroke, 35: 1276-1279.
[PMID:15118174]
14. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J. and Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Cell, 91: 521-530.
[PMID:9390561]
15. Jiang, Y., Salafranca, M. N., Adhikari, S., Xia, Y., Feng, L., Sonntag, M. K., deFiebre, C. M., Pennell, N. A., Streit, W. J. and Harrison, J. K. (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.
J Neuroimmunol, 86: 1-12.
[PMID:9655467]
16. Lavergne, E., Labreuche, J., Daoudi, M., Debré, P., Cambien, F., Deterre, P., Amarenco, P. and Combadiere, C. (2005) Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.
Arterioscler Thromb Vasc Biol., 25: 847-853.
[PMID:15681302]
17. Lesnik, P., Haskell, C. A. and Charo, I. F. (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.
J Clin Invest, 111: 333-340.
[PMID:12569158]
18. McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W., D'Agostino, R. B., O'Donnell, C. J., Patel, D. D. and Murphy, P. M. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
J Clin Invest, 111: 1241-1250.
[PMID:12697743]
19. McDermott, D. H., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A. and Murphy, P. M. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
Circ Res, 89: 401-407.
[PMID:11532900]
20. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W. and Miller, R. J. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.
Proc Natl Acad Sci U S A, 95: 14500-14505.
[PMID:9826729]
21. Moatti, D., Faure, S., Fumeron, F., Amara, M. e. l. -. W., Seknadji, P., McDermott, D. H., Debré, P., Aumont, M. C., Murphy, P. M., de Prost, D. and Combadiere, C. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Blood, 97: 1925-1928.
[PMID:11264153]
22. Niessner, A., Marculescu, R., Haschemi, A., Endler, G., Zorn, G., Weyand, C. M., Maurer, G., Mannhalter, C., Wojta, J., Wagner, O. and Huber, K. (2005) Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Thromb Haemost, 93: 949-954.
[PMID:15886814]
23. Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A. and Satoh, M. (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?.
FEBS Lett, 429: 167-172.
[PMID:9650583]
24. Oh, S. B., Endoh, T., Simen, A. A., Ren, D. and Miller, R. J. (2002) Regulation of calcium currents by chemokines and their receptors.
J Neuroimmunol, 123: 66-75.
[PMID:11880151]
25. Raport, C. J., Schweickart, V. L., Eddy, R. L., Shows, T. B. and Gray, P. W. (1995) The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues.
Gene, 163: 295-299.
[PMID:7590284]
26. Sbrana, S., Bevilacqua, S., Buffa, M., Spiller, D., Parri, M. S., Gianetti, J., De Filippis, R. and Clerico, A. (2005) Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation.
Cytometry B Clin Cytom, 65: 14-21.
[PMID:15786508]
27. Singh, K. K., Hughes, M. D., Chen, J. and Spector, S. A. (2005) Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
J Infect Dis, 191: 1971-1980.
[PMID:15871132]
28. Teupser, D., Pavlides, S., Tan, M., Gutierrez-Ramos, J. C., Kolbeck, R. and Breslow, J. L. (2004) Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.
Proc Natl Acad Sci U S A, 101: 17795-17800.
[PMID:15596719]
Annotated and expert reviewed. Please contact us if you can help with updates.
